Skip to main content
Equibles

Jonathan Violin, Ph.D.

Board Member

Korsana Biosciences, Inc. (KRSA)

CEO

Korsana Biosciences, Inc. (KRSA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Korsana Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get KRSA alerts

About Jonathan Violin, Ph.D.

Jonathan Violin, Ph.D. is recorded as Board Member and CEO at Korsana Biosciences, Inc. (KRSA) since September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Jonathan Violin, Ph.D. was appointed Board, effective September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Jonathan Violin, Ph.D. was appointed Chief Executive Officer and President, effective September 8, 2026. Korsana Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korsana Biosciences, Inc. includes Regina M. Graul (CEO and Board Member), Tomas Kiselak (Chairman and Board Member), Anjeza Gjino (CFO) and 7 others.

“On September 8, 2026, the Board fixed its size at six members and appointed the following six individuals to the Board: Andrew Gottesdiener, M.D., Heidi Henson, Tomas Kiselak, Michelle Pernice, Nimish Shah and Jonathan Violin, Ph.D.”
Korsana Biosciences, Inc. Form 8-K, filed September 11, 2026 · Read the filing
“On September 8, 2026, the Board appointed Jonathan Violin, Ph.D. as the Company’s Chief Executive Officer and President, Mark Vignola, Ph.D. as the Company’s Chief Financial Officer and Matthew Leoni, M.D. as the Company’s Chief Medical Officer, each to serve at the discretion of the Board.”
Korsana Biosciences, Inc. Form 8-K, filed September 11, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Korsana Biosciences, Inc.

Recent activity